Alumis · 8 hours ago
Director, Program Managment
Alumis Inc. is a precision medicines company focused on transforming the lives of patients with autoimmune diseases. They are seeking an experienced Director of Program Management to provide exceptional program management support for development molecules, partnering with various project teams to ensure effective communication and alignment across the organization.
BiotechnologyHealth CareLife ScienceMedicalPrecision Medicine
Responsibilities
Actively partner with Project Team Leads (PTLs) and Project Team PMs, providing leadership and guidance for team and to team members
Provide Project Management support by coordinating and aligning teams and associated workstreams, and managing their activities. This includes meeting facilitation, tracking of action items and team deliverables, to execute on program’s strategic plan and strategic objectives
Partner with other PMs (Ex. Molecule PMs (supporting Project Team, Clinical Development teams, etc), CMC PM, Medical Affairs PM, Launch PM) to ensure seamless PPM support across molecules
Ensure effective communication within functional team and stakeholders to support good decision-making in fast-paced small company environment
Proactively identify, analyze and communicate decision points and project risks, including tradeoff and scenario analyses (including timelines, costs, and risks), framing options within broader molecule or portfolio context
Identify needs and propose solutions to project and portfolio tools, systems and practices to support the growth and evolution of PPM’s capabilities
As needed, provide Business Manager support including but not limited to driving annual business process execution (Ex. goals, budget, performance reviews), maintaining strong functional dynamics, acting as function lead or representative for enterprise-wide initiatives, and facilitating transparency and alignment with other functions and teams at Alumis
As needed, act as a vendor liaison, providing contract, requisition processing, and invoice management support, as well as following up with vendor on project updates and status reports, to ensure timely and quality deliverables
As needed, support other business priorities within PPM, including but not limited to potential assignments in research, development, clinical, launch, medical affairs, or CMC project management
As needed, manage others
Qualification
Required
Minimum 12 years industry experience, with at least 5 years of drug development project management (e.g. research, clinical, CMC, commercial, medical affairs), including clinical development project management experience
Experience with filing and launch for small molecules
Highly skilled in communication, stakeholder management, and influencing without authority, where you are able to effectively interact with, and facilitate complex conversations across the organization
Excellent critical thinking, verbal and written communication skills, with ability to simplify and integrate multiple cross-functional perspectives and inputs for team
Agile and flexible: Able to step in, assess situations, and help team to make sound decisions in alignment with program strategy
Strong organizational skills with critical attention to detail and ability to track to numerous deliverables
Broad scientific and business acumen in the biotech or pharmaceutical industry, including a strong understanding of cross-functional dependencies
Proficient with Microsoft Office Suite, as well as project management software such as MS Project and Smartsheets
A. or BSc. with MSc., MBA or Ph.D. a plus
Preferred
Project Management Professional (PMP) or other PM certification a plus
Benefits
Health insurance premiums paid at 90% for employee, 80% for dependents
Free access to Genentech Bus & Ferry Share program
$100 monthly cell phone stipend
Unlimited PTO for Exempt employees
Free onsite gym and a kitchen stocked with yummy snacks and drinks!
Company
Alumis
Alumis is a precision medicine company focused on the discovery, development and treatment of autoimmune disorders.
Funding
Current Stage
Public CompanyTotal Funding
$917.19MKey Investors
Foresite CapitalMatrix Capital Management
2026-01-07Post Ipo Equity· $345.1M
2025-11-19Secondary Market· $3.09M
2024-07-23Post Ipo Equity· $40M
Recent News
Benzinga.com
2026-01-09
2026-01-09
Company data provided by crunchbase